AAA
TECX

Affinity Asset Advisors’s Tectonic Therapeutic TECX Stock Holding History

Affinity Asset Advisors’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-58,331
Closed -$2.69M – 114
2024
Q4 		$2.69M Hold
58,331
– – 0.36% 53
2024
Q3 		$1.77M Hold
58,331
– – 0.24% 67
2024
Q2 		$961K Sell
58,331
-2
-0% -$32 0.11% 82
2024
Q1 		$896K Buy
58,333
+16,666
+40% +$264K 0.11% 84
2023
Q4 		$680K Hold
41,667
– – 0.12% 73
2023
Q3 		$770K Buy
+41,667
New +$737K 0.22% 68

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Affinity Asset Advisors's TECX Position: Q1 2025 in Review

Affinity Asset Advisors sold out of Tectonic Therapeutic (TECX) in Q1 2025, closing a stake of 58,331 shares — an estimated $2.69M sold.

Affinity Asset Advisors first reported a position in TECX in Q3 2023 and held it in 6 quarters. The position peaked at $2.69M in Q4 2024. 78 funds tracked by Wall St. Rank hold TECX as of Q1 2025.

  • Affinity Asset Advisors reported no remaining Tectonic Therapeutic position as of Q1 2025 after selling out during the quarter.
  • Affinity Asset Advisors sold 58,331 Tectonic Therapeutic shares in Q1 2025, an estimated $2.69M.
  • Affinity Asset Advisors first reported a position in Tectonic Therapeutic in Q3 2023 and held it in 6 quarters.
  • Affinity Asset Advisors's Tectonic Therapeutic position peaked at $2.69M in Q4 2024.
  • 78 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2025.

Based on Affinity Asset Advisors's 13F filing for Q1 2025, filed 14 May 2025.